Monoclonal antibodies and binding fragments thereof directed to the melanocortin-4 receptor and their use in the treatment of cachexia and related conditions and diseases

Details for Australian Patent Application No. 2008200795 (hide)

Owner University of Basel

Inventors Jean-Christophe, Peter; Hofbauer, Karl

Agent Griffith Hack

Pub. Number AU-A-2008200795

Priority 61/018,360 31.12.07 US; 61/029,661 19.02.08 US

Filing date 20 February 2008

Wipo publication date 16 July 2009

International Classifications

C07K 16/28 (2006.01) Immunoglobulins, e.g. monoclonal or polyclonal antibodies

A61K 31/00 (2006.01)

A61K 39/00 (2006.01) Medicinal preparations containing antigens or antibodies

A61P 3/04 (2006.01) Drugs for disorders of the metabolism

Event Publications

6 March 2008 Complete Application Filed

  Priority application(s): 61/018,360 31.12.07 US; 61/029,661 19.02.08 US

16 July 2009 Application Open to Public Inspection

  Published as AU-A-2008200795

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2008200796-Current supply circuit, polyphase drive circuit, method of designing current supply circuit

2008200794-Methods for diagnosing and treating obesity by modulating the activity of auto-antibodies against the melanocortin-4 receptor